Back | Next |
home / stock / nrbo / nrbo message board
Subject | By | Source | When |
---|---|---|---|
$NRBO Time for a bounce? | SmellMyFinger | investorshub | 01/25/2024 5:35:59 AM |
$NRBO short squeeze all day | SmellMyFinger | investorshub | 01/25/2024 4:16:02 AM |
The trading | tw0122 | investorshub | 01/24/2024 11:02:27 PM |
Time for a bounce? | tw0122 | investorshub | 01/24/2024 10:07:56 PM |
should we be shorting? | tw0122 | investorshub | 01/24/2024 9:06:38 PM |
$NRBO short squeeze signal | 81vette | investorshub | 01/24/2024 8:39:15 PM |
$NRBO Long and strong lets hope im right | tw0122 | investorshub | 01/24/2024 7:55:59 PM |
$NRBO Good read | FROZENFLAME | investorshub | 01/24/2024 7:33:56 PM |
$NRBO what do you make of this data? | friendVA | investorshub | 01/24/2024 6:43:36 PM |
MomentumIts now | Invest-in-America | investorshub | 01/24/2024 3:20:24 PM |
$NRBO Anyone hear anything lately? Want to see this one go | SmellMyFinger | investorshub | 01/24/2024 10:49:34 AM |
The gaining | BesaoT35 | investorshub | 01/24/2024 8:10:35 AM |
$NRBO Looks pretty positive | BesaoT35 | investorshub | 01/24/2024 7:20:17 AM |
The trading up | glens0 | investorshub | 01/24/2024 3:25:09 AM |
Price now up | 81vette | investorshub | 01/23/2024 8:33:26 PM |
Nothing but crickets here lately. | SmellMyFinger | investorshub | 01/23/2024 4:30:09 PM |
The now | SmellMyFinger | investorshub | 01/23/2024 3:50:19 PM |
$NRBO The now up | BesaoT35 | investorshub | 01/23/2024 3:44:32 PM |
MomentumIts now last up | 81vette | investorshub | 01/23/2024 11:20:26 AM |
$NRBO what do you make of this data? | SmellMyFinger | investorshub | 01/23/2024 8:40:01 AM |
News, Short Squeeze, Breakout and More Instantly...
NeuroBo Pharmaceuticals Inc. Company Name:
NRBO Stock Symbol:
NASDAQ Market:
NeuroBo Pharmaceuticals Inc. Website:
NeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Asce...
NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon ...
NeuroBo Pharmaceuticals Announces up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon the exercise in...